Stacie Bell

1.0k total citations · 1 hit paper
35 papers, 598 citations indexed

About

Stacie Bell is a scholar working on Immunology, Infectious Diseases and Surgery. According to data from OpenAlex, Stacie Bell has authored 35 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Infectious Diseases and 6 papers in Surgery. Recurrent topics in Stacie Bell's work include Psoriasis: Treatment and Pathogenesis (7 papers), Amoebic Infections and Treatments (4 papers) and Anorectal Disease Treatments and Outcomes (3 papers). Stacie Bell is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (7 papers), Amoebic Infections and Treatments (4 papers) and Anorectal Disease Treatments and Outcomes (3 papers). Stacie Bell collaborates with scholars based in United States, United Kingdom and Japan. Stacie Bell's co-authors include April W. Armstrong, George Gondo, C.E.M. Griffiths, Clayton W. Schupp, Manan D. Mehta, A. W. Woodruff, Sharon J. Carlson, George N. Cox, Daniel H. Doherty and Elizabeth A. Chlipala and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Stacie Bell

31 papers receiving 573 citations

Hit Papers

Psoriasis Prevalence in Adults in the United States 2021 2026 2022 2024 2021 50 100 150 200 250

Peers

Stacie Bell
M. J. Boffa United Kingdom
Emine Derviş Türkiye
Susanne Loeliger Switzerland
Lindsay C. Strowd United States
M. Buffet France
Robert B. Skinner United States
M. J. Boffa United Kingdom
Stacie Bell
Citations per year, relative to Stacie Bell Stacie Bell (= 1×) peers M. J. Boffa

Countries citing papers authored by Stacie Bell

Since Specialization
Citations

This map shows the geographic impact of Stacie Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacie Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacie Bell more than expected).

Fields of papers citing papers by Stacie Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacie Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacie Bell. The network helps show where Stacie Bell may publish in the future.

Co-authorship network of co-authors of Stacie Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Stacie Bell. A scholar is included among the top collaborators of Stacie Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacie Bell. Stacie Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caricchio, Roberto, Stacie Bell, Sasha Bernatsky, et al.. (2025). A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases. ACR Open Rheumatology. 7(12). e70139–e70139.
2.
Pinter, Andreas, Satomi Kobayashi, Stacie Bell, et al.. (2023). Understanding potential participation barriers to improve trial design and outcomes: clinical trial simulation in palmoplantar pustulosis as a case study. BMJ Open. 13(4). e064159–e064159.
3.
Armstrong, April W., Emily Edson‐Heredia, Baojin Zhu, et al.. (2022). Treatment Goals for Psoriasis as Measured by Patient Benefit Index: Results of a National Psoriasis Foundation Survey. Advances in Therapy. 39(6). 2657–2667. 8 indexed citations
4.
Gondo, George, Edward Hadeler, Nicholas Brownstone, et al.. (2022). Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriasis. Dermatology and Therapy. 12(3). 753–760. 3 indexed citations
5.
Bell, Stacie, Jacqueline S. Domire, Joseph F. Merola, A.B. Gottlieb, & George Gondo. (2020). 495 The impact of psoriasis and its associated comorbidities on quality of life: Results from the National Psoriasis Foundation Annual Survey. Journal of Investigative Dermatology. 140(7). S67–S67. 1 indexed citations
6.
Bell, Stacie, Joseph F. Merola, Dan E. Webster, et al.. (2020). Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMAN. Current Rheumatology Reports. 22(11). 78–78. 11 indexed citations
7.
Bell, Stacie, et al.. (2020). Psoriatic arthritis; overcoming the challenges by creating opportunities. Clinical Immunology. 218. 108519–108519. 2 indexed citations
8.
Gondo, George, Jacqueline S. Domire, Joseph F. Merola, A.B. Gottlieb, & Stacie Bell. (2020). 459 Understanding the impact of psoriatic disease on mental health: Results from the National Psoriasis Foundation Annual Survey. Journal of Investigative Dermatology. 140(7). S61–S61. 1 indexed citations
9.
Bell, Stacie, et al.. (2020). A 12-month feasibility study to investigate the effectiveness of cryogen-cooled monopolar radiofrequency treatment for female stress urinary incontinence. Canadian Urological Association Journal. 14(7). E313–E318. 8 indexed citations
10.
Bell, Stacie, et al.. (2019). Early Feasibility Study to Evaluate the Viveve System for Female Stress Urinary Incontinence: Interim 6-Month Report. Journal of Women s Health. 29(3). 383–389. 5 indexed citations
11.
Saviolakis, George A., Wael Elamin, Blaire L. Osborn, et al.. (2019). Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota. Antimicrobial Agents and Chemotherapy. 64(1). 22 indexed citations
13.
Wenzel, Sally E., David Chantry, Robert W. Hopkins, et al.. (2014). ARRY-502, a potent, selective, oral CRTh2 antagonist reduces Th2 mediators in patients with mild to moderate Th2-driven asthma. European Respiratory Journal. 44(Suppl 58). 4836–4836. 4 indexed citations
14.
Cox, George N., Elizabeth A. Chlipala, Darin Smith, et al.. (2014). Hematopoietic Properties of Granulocyte Colony-Stimulating Factor/Immunoglobulin (G-CSF/IgG-Fc) Fusion Proteins in Normal and Neutropenic Rodents. PLoS ONE. 9(3). e91990–e91990. 21 indexed citations
15.
Wenzel, Sally E., Robert W. Hopkins, Michael D. Saunders, et al.. (2014). Safety and Efficacy Of ARRY-502, a Potent, Selective, Oral CRTh2 Antagonist, In Patients With Mild To Moderate Th2-Driven Asthma. Journal of Allergy and Clinical Immunology. 133(2). AB4–AB4. 14 indexed citations
16.
Bell, Stacie, Jennifer Vincent, Karen Welch, et al.. (2014). A Comparison of the Safety/Tolerability and Pharmacodynamics of ActharGel and Methylprednisolone with Regimens Utilized for the Treatment of MS Exacerbations (P2.207). Neurology. 82(10_supplement). 1 indexed citations
17.
Faqi, Ali S., Stacie Bell, Stan Gill, & Dorothy B. Colagiovanni. (2009). An intranasal irritation assessment of antibacterial ointment alone or in combination with mupirocin versus Bactroban Nasal® in rabbits. Regulatory Toxicology and Pharmacology. 55(1). 28–32. 2 indexed citations
18.
Twomey, D. F., Alex Barlow, Stacie Bell, et al.. (2007). Cryptosporidiosis in two alpaca (Lama pacos) holdings in the South-West of England. The Veterinary Journal. 175(3). 419–422. 28 indexed citations
19.
Woodruff, A. W. & Stacie Bell. (1967). The evaluation of amoebicides. Transactions of the Royal Society of Tropical Medicine and Hygiene. 61(3). 435–439. 10 indexed citations
20.
Bell, Stacie. (1967). An investigation of carriers of Entamoeba histolytica. Transactions of the Royal Society of Tropical Medicine and Hygiene. 61(4). 506–513. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026